381 related articles for article (PubMed ID: 17761519)
21. Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects.
Jackson JG; St Clair P; Sliwkowski MX; Brattain MG
Cancer Res; 2004 Apr; 64(7):2601-9. PubMed ID: 15059917
[TBL] [Abstract][Full Text] [Related]
22. Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium.
Xu C; Rosler E; Jiang J; Lebkowski JS; Gold JD; O'Sullivan C; Delavan-Boorsma K; Mok M; Bronstein A; Carpenter MK
Stem Cells; 2005 Mar; 23(3):315-23. PubMed ID: 15749926
[TBL] [Abstract][Full Text] [Related]
23. AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor, ERBB2 (HER2), and ERBB3: a unique agent for simultaneous ERBB receptor blockade in cancer.
Hickinson DM; Klinowska T; Speake G; Vincent J; Trigwell C; Anderton J; Beck S; Marshall G; Davenport S; Callis R; Mills E; Grosios K; Smith P; Barlaam B; Wilkinson RW; Ogilvie D
Clin Cancer Res; 2010 Feb; 16(4):1159-69. PubMed ID: 20145185
[TBL] [Abstract][Full Text] [Related]
24. Expression of heregulin alpha, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells.
Noguchi H; Sakamoto C; Wada K; Akamatsu T; Uchida T; Tatsuguchi A; Matsui H; Fukui H; Fujimori T; Kasuga M
Gastroenterology; 1999 Nov; 117(5):1119-27. PubMed ID: 10535875
[TBL] [Abstract][Full Text] [Related]
25. c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function.
Ishizawar RC; Miyake T; Parsons SJ
Oncogene; 2007 May; 26(24):3503-10. PubMed ID: 17173075
[TBL] [Abstract][Full Text] [Related]
26. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
[TBL] [Abstract][Full Text] [Related]
27. Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells.
Vallier L; Alexander M; Pedersen RA
J Cell Sci; 2005 Oct; 118(Pt 19):4495-509. PubMed ID: 16179608
[TBL] [Abstract][Full Text] [Related]
28. Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells.
Xiao L; Yuan X; Sharkis SJ
Stem Cells; 2006 Jun; 24(6):1476-86. PubMed ID: 16456129
[TBL] [Abstract][Full Text] [Related]
29. Presence of EGF growth factor ligands and their effects on cultured rat conjunctival goblet cell proliferation.
Gu J; Chen L; Shatos MA; Rios JD; Gulati A; Hodges RR; Dartt DA
Exp Eye Res; 2008 Feb; 86(2):322-34. PubMed ID: 18155194
[TBL] [Abstract][Full Text] [Related]
30. Synergistic effect of medium, matrix, and exogenous factors on the adhesion and growth of human pluripotent stem cells under defined, xeno-free conditions.
Meng G; Liu S; Rancourt DE
Stem Cells Dev; 2012 Jul; 21(11):2036-48. PubMed ID: 22149941
[TBL] [Abstract][Full Text] [Related]
31. Dissecting signaling pathways that govern self-renewal of rabbit embryonic stem cells.
Wang S; Shen Y; Yuan X; Chen K; Guo X; Chen Y; Niu Y; Li J; Xu RH; Yan X; Zhou Q; Ji W
J Biol Chem; 2008 Dec; 283(51):35929-40. PubMed ID: 18940811
[TBL] [Abstract][Full Text] [Related]
32. Human embryonic stem cells maintained in the absence of mouse embryonic fibroblasts or conditioned media are capable of hematopoietic development.
Wang L; Li L; Menendez P; Cerdan C; Bhatia M
Blood; 2005 Jun; 105(12):4598-603. PubMed ID: 15718421
[TBL] [Abstract][Full Text] [Related]
33. Leukemia inhibitory factor-induced Stat3 signaling suppresses fibroblast growth factor 1-induced Erk1/2 activation to inhibit the downstream differentiation in mouse embryonic stem cells.
Liu JW; Hsu YC; Kao CY; Su HL; Chiu IM
Stem Cells Dev; 2013 Apr; 22(8):1190-7. PubMed ID: 23205673
[TBL] [Abstract][Full Text] [Related]
34. Maintenance of human pluripotent stem cells using 4SP-hFGF2-secreting STO cells.
Lee WY; Kim J; Gil CH; Lee JH; Song H; Kim JH; Chung HM
Stem Cell Res; 2011 Nov; 7(3):210-8. PubMed ID: 21907164
[TBL] [Abstract][Full Text] [Related]
35. The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells.
Bowers G; Reardon D; Hewitt T; Dent P; Mikkelsen RB; Valerie K; Lammering G; Amir C; Schmidt-Ullrich RK
Oncogene; 2001 Mar; 20(11):1388-97. PubMed ID: 11313882
[TBL] [Abstract][Full Text] [Related]
36. ErbB2 and EGFR are downmodulated during the differentiation of 3T3-L1 preadipocytes.
Pagano E; Calvo JC
J Cell Biochem; 2003 Oct; 90(3):561-72. PubMed ID: 14523990
[TBL] [Abstract][Full Text] [Related]
37. Comparative study of mouse and human feeder cells for human embryonic stem cells.
Eiselleova L; Peterkova I; Neradil J; Slaninova I; Hampl A; Dvorak P
Int J Dev Biol; 2008; 52(4):353-63. PubMed ID: 18415935
[TBL] [Abstract][Full Text] [Related]
38. Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes.
Stoll SW; Kansra S; Peshick S; Fry DW; Leopold WR; Wiesen JF; Sibilia M; Zhang T; Werb Z; Derynck R; Wagner EF; Elder JT
Neoplasia; 2001; 3(4):339-50. PubMed ID: 11571634
[TBL] [Abstract][Full Text] [Related]
39. Maintenance of human embryonic stem cells in media conditioned by human mesenchymal stem cells obviates the requirement of exogenous basic fibroblast growth factor supplementation.
Sánchez L; Gutierrez-Aranda I; Ligero G; Martín M; Ayllón V; Real PJ; Ramos-Mejía V; Bueno C; Menendez P
Tissue Eng Part C Methods; 2012 May; 18(5):387-96. PubMed ID: 22136131
[TBL] [Abstract][Full Text] [Related]
40. FGF-2 modulates Wnt signaling in undifferentiated hESC and iPS cells through activated PI3-K/GSK3beta signaling.
Ding VM; Ling L; Natarajan S; Yap MG; Cool SM; Choo AB
J Cell Physiol; 2010 Nov; 225(2):417-28. PubMed ID: 20506199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
